Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
JPMorgan's survey reveals low coverage of weight-loss drugs compared to diabetes medications among large employers. The demand for these drugs poses challenges due to costs, with only a portion of companies planning to expand coverage in the future.